Gröbner W, Walter-Sack I, de Vries J X
Innere Abteilung, Kreiskrankenhaus, Balingen, Germany.
Eur J Med Res. 1998 Feb 21;3(1-2):77-80.
A 49 year old female patient with anorexia nervosa was admitted to the hospital because of treatment-refractory hyperuricemia and gout. Medical history and clinical findings were compatible with primary gout and uric acid nephropathy. The patient stated that she regularly took allopurinol. In the hospital she initially received 300 mg allopurinol daily after breakfast. In order to ensure allopurinol ingestion and absorption the plasma concentrations of both allopurinol and its active metabolite oxipurinol were determined in addition to serum uric acid and further clinical chemistry data. Despite allopurinol treatment no decrease of serum uric acid was observed for three days. Therefore the head nurse was instructed to supervise the intake of allopurinol carefully. During the following days serum uric acid decreased and plasma oxipurinol concentrations rose. On day 9 of treatment serum uric acid fell into the upper normal range. Therefore the patient was allowed to leave the hospital within a few days. However serum uric acid thereafter increased again while plasma oxipurinol declined. Later on it became evident that the patient had vomited self-induced approximately 15 minutes after allopurinol intake. In the meantime her husband had urged her to return home. Starting with day 18 benzbromarone treatment was added. Combined therapy with 400 mg allopurinol and 50 mg benzbromarone daily finally resulted in a serum uric acid concentration of 4.5 mg/dl at discharge from the hospital. About three weeks later the private physician again diagnosed hyperuricemia with serum uric acid values between 10 and 12 mg/dl. Meanwhile the patient needs to be dialysed due to end stage renal disease. Our observations show that self-induced vomiting to prevent effective treatment may be a disease-specific pattern of noncompliance with drug therapy in anorexia nervosa.
一名49岁的神经性厌食症女性患者因难治性高尿酸血症和痛风入院。病史和临床检查结果与原发性痛风和尿酸肾病相符。患者称她定期服用别嘌醇。在医院,她最初每天早餐后服用300毫克别嘌醇。为确保别嘌醇的摄入和吸收,除测定血清尿酸和其他临床化学数据外,还测定了别嘌醇及其活性代谢产物氧嘌呤醇的血浆浓度。尽管进行了别嘌醇治疗,但三天内血清尿酸未见下降。因此,护士长被指示仔细监督别嘌醇的服用情况。在接下来的几天里,血清尿酸下降,血浆氧嘌呤醇浓度上升。治疗第9天,血清尿酸降至正常上限范围内。因此,患者在几天内被允许出院。然而,此后血清尿酸再次升高,而血浆氧嘌呤醇下降。后来发现,患者在服用别嘌醇后约15分钟自行呕吐。与此同时,她的丈夫催促她回家。从第18天开始,加用苯溴马隆治疗。每天联合使用400毫克别嘌醇和50毫克苯溴马隆治疗,最终患者出院时血清尿酸浓度为4.5毫克/分升。大约三周后,私人医生再次诊断为高尿酸血症,血清尿酸值在10至12毫克/分升之间。与此同时,患者因终末期肾病需要进行透析。我们的观察结果表明,为防止有效治疗而自行呕吐可能是神经性厌食症患者药物治疗不依从的一种疾病特异性模式。